A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae

mBio

Volumn 2, Issue 5, 2011, Pages

  Ohneck, Elizabeth A ^a   Zalucki, Yaramah M ^a   Johnson, Paul J T ^a   Dhulipala, Vijaya ^a   Golparian, Daniel ^b   Unemo, Magnus ^b   Jerse, Ann E ^c   Shafer, William M ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE REPRESSION; GENETIC REGULATION; GENETIC TRANSCRIPTION; MRTCDE GENE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS); NEISSERIA; NEISSERIA GONORRHOEAE;

EID: 80455132320     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00187-11     Document Type: Article

References (45)

1. Hagman KE, et al. 1995. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 141:611-622.
2. Lee EH, Shafer WM. 1999. The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids. Mol. Mi-crobiol. 33:839-845.
3. Pan W, Spratt BG. 1994. Regulation of the permeability of the gonococcal cell envelope by the mtr system. Mol. Microbiol. 11:769-775.
4. Rouquette-Loughlin CE, Balthazar JT, Shafer WM. 2005. Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. J. Antimi-crob. Chemother. 56:856-860.
5. Rouquette-Loughlin C, Dunham SA, Kuhn M, Balthazar JT, Shafer WM. 2003. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J. Bacteriol. 185:1101-1106.
6. Shafer WM, Qu X-D, Waring AJ, Lehrer RI. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 95:1829-1833.
7. Hagman KE, Shafer WM. 1995. Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J. Bacteriol. 177:4162-4165.
8. Rouquette C, Harmon JB, Shafer WM. 1999. Induction of the mtrCDE-encoded efflux pump system of Neisseria gonorrhoeae requires MtrA, an AraC-like protein. Mol. Microbiol. 33:651-658.
9. Shafer WM, Folster JP, Nicholas RA. 2010. Molecular mechanisms of antibiotic resistance expressed by the pathogenic Neisseria. In Genco C, Wetzler L (ed.), Neisseria: molecular mechanisms ofpathogenesis. Caister Academic Press, Norfolk, United Kingdom.
10. Hoffmann KM, Williams D, Shafer WM, Brennan RG. 2005. Characterization of the multiple transferable resistance repressor, MtrR, from Neisseria gonorrhoeae. J. Bacteriol. 187:5008-5012.
11. Shafer WM, Balthazar JT, Hagman KE, Morse SA. 1995. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology 141:907-911.
12. Warner DM, Shafer WM, Jerse AE. 2008. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol. Microbiol. 70:462-478.
13. Swanson J. 1973. Studies on gonococcus infection IV. Pili: their role in attachment of gonococci to tissue culture cells. J. Exp. Med. 137:571-589.
14. Browning DF, Busby SJW. 2004. The regulation of bacterial transcription initiation. Nat. Rev. Microbiol. 2:57-65.
15. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. 2009. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J. Antimicrob. Chemother. 63:1142-1151.
16. Silver LE, Clark VL. 1995. Construction of a translational lacZ fusion system to study gene regulation in Neisseria gonorrhoeae. Gene 166: 101-104.
17. Lucas CE, Balthazar JT, Hagman KE, Shafer WM. 1997. The MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae. J. Bacteriol. 179:4123- 4128.
18. Shine J, Dalgarno L. 1975. Determinant of cistron specificity in bacterial ribosomes. Nature 254:34-38.
19. Folster JP, et al. 2009. MtrR modulates rpoH expression and levels of antimicrobial resistance in Neisseria gonorrhoeae. J. Bacteriol. 191: 287-297.
20. Warner DM, Folster JP, Shafer WM, Jerse AE. 2007. Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J. Infect. Dis. 196:1804-1812.
21. Eisenstein BI, Sparling PF. 1978. Mutations to increased antibiotic sensitivity in naturally-occurring gonococci. Nature 271:242-244.
22. Chaussee MS, Wilson J, Hill SA. 1999. Characterization of the recD gene of Neisseria gonorrhoeae MS11 and the effect of recD inactivation on pilin variation and DNA transformation. Microbiology 145:389-400.
23. Haas R, Meyer TF. 1986. The repertoire of silent pilus genes in Neisseria gonorrhoeae: evidence for gene conversion. Cell 44:107-115.
24. Haas R, Veit S, Meyer TF. 1992. Silent pilin genes of Neisseria gonor-rhoeaeMS11 and the occurrence of related hypervariant sequences among other gonococcal isolates. Mol. Microbiol. 6:197-208.
25. Manning PA, et al. 1991. L-pilin variants of Neisseria gonorrhoeae MS11. Mol. Microbiol. 5:917-926.
26. Bhat KS, et al. 1991. The opacity proteins of Neisseria gonorrhoeae strain MS11 are encoded by a family of 11 complete genes. Mol. Microbiol. 5:1889-1901.
27. Bos MP, Kuroki M, Krop-Watorek A, Hogan D, Belland RJ. 1998. CD66 receptor specificity exhibited by neisserial Opa variants is controlled by protein determinants in CD66 N-domains. Proc. Natl. Acad. Sci. U. S. A. 95:9584-9589.
28. Criss AK, Seifert HS. 2008. Neisseria gonorrhoeae suppresses the oxidative burst of human polymorphonuclear leukocytes. Cell. Microbiol. 10: 2257-2270.
29. Bergman P, et al. 2005. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell. Microbiol. 7:1009-1017.
30. Carbonetti N, Simnad V, Elkins C, Sparling PF. 1990. Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics. Mol. Microbiol. 4:1009-1018.
31. Schneider H, et al. 1991. Expression of paraglobiside-like lipooligosac-charides may be a necessary component of gonococcal pathogenesis in men. J. Exp. Med. 174:1601-1605.
32. Swanson J, et al. 1987. Gonococcal pilin variants in experimental gonorrhea. J. Exp. Med. 165:1344-1357.
33. Ramsey KH, et al. 1995. Inflammatory cytokines produced in response to experimental human gonorrhea. J. Infect. Dis. 172:186-191.
34. Schmidt KA, et al. 2001. Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers. Sex. Transm. Dis. 28:555-564.
35. Hobbs MM, et al. 2011. Experimental gonococcal infection in male volunteers: cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC. Front. Microbiol. 2:123.
36. Shafer WM, Guymon LF, Lind I, Sparling PF. 1984. Identification of an envelope mutation (env-10) resulting inincreased antibiotic susceptibility and pyocin resistance in a clinical isolate of Neisseria gonorrhoeae. Antimi-crob. Agents Chemother. 25:767-769.
37. Gunn JS, Stein DC. 1996. Use of a non-selective transformation tech-niquetoconstruct amultiply restriction/modification-deficient mutant of Neisseria gonorrhoeae. Mol. Gen. Genet. 251:509-517.
38. Baker RF, Yanofsky C. 1968. The periodicity of RNA polymerase initiations: a new regulatory feature of transcription. Proc. Natl. Acad. Sci. U. S. A. 60:313-320.
39. Snyder LAS, Shafer WM, Saunders NJ. 2003. Divergence and transcrip-tional analysis of the division cell wall (dcw) gene cluster in Neisseria spp. Mol. Microbiol. 47:431-442.
40. Unemo M, Olcén P, Berglund T, Albert J, Fredlund H. 2002. Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J. Clin. Microbiol. 40: 3741-3749.
41. Berglund T, Unemo M, Olcen P, Giesecke J, Fredlund H. 2002. One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int. J. STD AIDS 13:109-114.
42. Mavroidi A, et al. 2001. Multidrug-resistant strains of Neisseria gonor-rhoeae in Greece. Antimicrob. Agents Chemother. 45:2651-2654.
43. Lindberg R, Fredlund H, Nicholas R, Unemo M. 2007. Neisseria gonor-rhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms inpenA,mtrR, porB1b, andponA. Antimicrob. Agents Chemother. 51:2117-2122.
44. Delahay RM, Robertson BD, Balthazar JT, Shafer WM, Ison CA. 1997. Involvement of the gonococcal MtrE protein in the resistance of Neisseria gonorrhoeae to toxic hydrophobic agents. Microbiology 143:2127-2133.
45. Sarubbi FA Jr, Blackman E, Sparling PF. 1974. Genetic mapping of linked antibiotic resistance loci in Neisseria goneorrhoeae. J. Bacteriol. 120: 1284-1292.